Influence of Artificial Intelligence on Drug Discovery and Development

Share this:
Published: 6 Jul 2018

The Genetic Technology TechVision Opportunity Engine (TOE) outlines the impact of artificial intelligence (AI) on the global drug discovery and development landscape. Berg Health’s precision medicine platforms and a clinical overview of the company’s pipeline have been profiled in the TOE. Furthermore, IP trends, research aspects, and AI-medicine strategies have also been described. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Artificial intelligence, drug discovery, drug development, precision medicine



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..